Characteristics and outcomes of lean versus non-lean metabolic dysfunction-associated steatohepatitis liver transplant recipients.
INTRODUCTION AND OBJECTIVES Metabolic dysfunction-associated steatohepatitis (MASH) is a leading indication for liver transplantation (LT) in the United States, yet outcomes among lean MASH recipients remain poorly defined. Lean patients represent a biologically distinct phenotype with lower body mass index but compara...